Equillium
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Equillium and other ETFs, options, and stocks.About EQ
Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6.
CEOBruce D. Steel
CEOBruce D. Steel
Employees35
Employees35
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2017
Founded2017
Employees35
Employees35
EQ Key Statistics
Market cap54.56M
Market cap54.56M
Price-Earnings ratio-1.63
Price-Earnings ratio-1.63
Dividend yield—
Dividend yield—
Average volume417.68K
Average volume417.68K
High today$1.00
High today$1.00
Low today$0.915
Low today$0.915
Open price$0.98
Open price$0.98
Volume310.37K
Volume310.37K
52 Week high$2.35
52 Week high$2.35
52 Week low$0.27
52 Week low$0.27
Stock Snapshot
Equillium(EQ) stock is priced at $0.96, giving the company a market capitalization of 54.56M. It carries a P/E multiple of -1.63.
On 2025-11-13, Equillium(EQ) stock moved within a range of $0.92 to $1.00. With shares now at $0.96, the stock is trading +4.4% above its intraday low and -4.4% below the session's peak.
Trading volume for Equillium(EQ) stock has reached 310.37K, versus its average volume of 417.68K.
Over the past 52 weeks, Equillium(EQ) stock has traded between a high of $2.35 and a low of $0.27.
Over the past 52 weeks, Equillium(EQ) stock has traded between a high of $2.35 and a low of $0.27.
People also own
Based on the portfolios of people who own EQ. This list is generated using Robinhood data, and it’s not a recommendation.